Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Axolabs, Mirrx, TriPhos, and More

Premium

Title: Alternative Export Pathways for Vector-expressed RNA Interference

Patent Number: 8,691,567

Filed: June 21, 2012

Lead Inventor: Scott Harper, University of Iowa


Title: Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds

Patent Number: 8,691,750

Filed: May 8, 2012

Lead Inventor: Rainer Constien, Axolabs


Title: Compositions for Treating Respiratory Viral Infections and Their Use

Patent Number: 8,691,781

Filed: June 1, 2007

Lead Inventor: Qingquan Tang, Sirnaomics


Title: Compositions and Methods for Non-parenteral Delivery of Oligonucleotides

Patent Number: 8,691,785

Filed: Jan. 7, 2013

Lead Inventor: Ching-Leou Teng, Isis Pharmaceuticals


Title: Methods and Compositions for the Specific Inhibition of Gene Expression by Double-stranded RNA

Patent Number: 8,691,786

Filed: Jan. 24, 2013

Lead Inventor: John Rossi, City of Hope


Title: Delivering Functional Nucleic Acids to Mammalian Cells via Bacterially Derived, Intact Minicells

Patent Number: 8,691,963

Filed: Aug. 25, 2005

Lead Inventor: Himanshu Brahmbhatt, Engeneic Molecular Delivery


Title: Oligonucleotides for Modulating Target RNA Activity

Patent Number: 8,691,965

Filed: June 13, 2008

Inventor: Thorleif Moller, Mirrx Therapeutics


Title: Multiple Promoter Expression Cassettes for Simultaneous Delivery of RNAi Agents

Patent Number: 8,691,967

Filed: Sept. 26, 2012

Lead Inventor: Petrus Roelvink, Benitec


Title: Self-delivering Bio-labile Phosphate Pro-oligos for Oligonucleotide-based Therapeutics and Mediating RNA Interference

Patent Number: 8,691,971

Filed: Sept. 23, 2009

Inventor: Scott Petersen, Traversa Therapeutics (TriPhos Therapeutics)

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.